Trials / Conditions / Renal Cell Cancer, Recurrent
Renal Cell Cancer, Recurrent
3 registered clinical trials studyying Renal Cell Cancer, Recurrent — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC NCT07197580 | Telix Pharmaceuticals (Innovations) Pty Limited | Phase 3 |
| Active Not Recruiting | A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cel NCT03634540 | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Terminated | Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or NCT03013946 | AIO-Studien-gGmbH | Phase 3 |